128 related articles for article (PubMed ID: 35732217)
1. Nootropic effects of LSD: Behavioral, molecular and computational evidence.
Ornelas IM; Cini FA; Wießner I; Marcos E; Araújo DB; Goto-Silva L; Nascimento J; Silva SRB; Costa MN; Falchi M; Olivieri R; Palhano-Fontes F; Sequerra E; Martins-de-Souza D; Feilding A; Rennó-Costa C; Tófoli LF; Rehen SK; Ribeiro S
Exp Neurol; 2022 Oct; 356():114148. PubMed ID: 35732217
[TBL] [Abstract][Full Text] [Related]
2. Return of the lysergamides. Part V: Analytical and behavioural characterization of 1-butanoyl-d-lysergic acid diethylamide (1B-LSD).
Brandt SD; Kavanagh PV; Westphal F; Stratford A; Elliott SP; Dowling G; Wallach J; Halberstadt AL
Drug Test Anal; 2019 Aug; 11(8):1122-1133. PubMed ID: 31083768
[TBL] [Abstract][Full Text] [Related]
3. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
Hungen KV; Roberts S; Hill DF
Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
[TBL] [Abstract][Full Text] [Related]
4. Modulation of DNA methylation and protein expression in the prefrontal cortex by repeated administration of D-lysergic acid diethylamide (LSD): Impact on neurotropic, neurotrophic, and neuroplasticity signaling.
Inserra A; Campanale A; Cheishvili D; Dymov S; Wong A; Marcal N; Syme RA; Taylor L; De Gregorio D; Kennedy TE; Szyf M; Gobbi G
Prog Neuropsychopharmacol Biol Psychiatry; 2022 Dec; 119():110594. PubMed ID: 35777526
[TBL] [Abstract][Full Text] [Related]
5. Role of the 5-HT
Preller KH; Schilbach L; Pokorny T; Flemming J; Seifritz E; Vollenweider FX
J Neurosci; 2018 Apr; 38(14):3603-3611. PubMed ID: 29555857
[TBL] [Abstract][Full Text] [Related]
6. Lysergic acid diethylamide differentially modulates the reticular thalamus, mediodorsal thalamus, and infralimbic prefrontal cortex: An in vivo electrophysiology study in male mice.
Inserra A; De Gregorio D; Rezai T; Lopez-Canul MG; Comai S; Gobbi G
J Psychopharmacol; 2021 Apr; 35(4):469-482. PubMed ID: 33645311
[TBL] [Abstract][Full Text] [Related]
7. Serotonin type 5A receptor antagonists inhibit D-lysergic acid diethylamide discriminatory cue in rats.
Popik P; Krawczyk M; Kuziak A; Bugno R; Hogendorf A; Staroń J; Nikiforuk A
J Psychopharmacol; 2019 Nov; 33(11):1447-1455. PubMed ID: 31452444
[TBL] [Abstract][Full Text] [Related]
8. Modulation of long-term potentiation following microdoses of LSD captured by thalamo-cortical modelling in a randomised, controlled trial.
Murphy RJ; Godfrey K; Shaw AD; Muthukumaraswamy S; Sumner RL
BMC Neurosci; 2024 Feb; 25(1):7. PubMed ID: 38317077
[TBL] [Abstract][Full Text] [Related]
9. Re-evaluation of the discriminative stimulus effects of lysergic acid diethylamide with male and female Sprague-Dawley rats.
Herr KA; Baker LE
Behav Pharmacol; 2020 Dec; 31(8):776-786. PubMed ID: 32960851
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD).
Halberstadt AL; Chatha M; Klein AK; McCorvy JD; Meyer MR; Wagmann L; Stratford A; Brandt SD
Neuropharmacology; 2020 Aug; 172():107856. PubMed ID: 31756337
[TBL] [Abstract][Full Text] [Related]
11. Effects of repeated lysergic acid diethylamide (LSD) on the mouse brain endocannabinoidome and gut microbiome.
Inserra A; Giorgini G; Lacroix S; Bertazzo A; Choo J; Markopolous A; Grant E; Abolghasemi A; De Gregorio D; Flamand N; Rogers G; Comai S; Silvestri C; Gobbi G; Di Marzo V
Br J Pharmacol; 2023 Mar; 180(6):721-739. PubMed ID: 36316276
[TBL] [Abstract][Full Text] [Related]
12. Dark Classics in Chemical Neuroscience: Lysergic Acid Diethylamide (LSD).
Nichols DE
ACS Chem Neurosci; 2018 Oct; 9(10):2331-2343. PubMed ID: 29461039
[TBL] [Abstract][Full Text] [Related]
13. The paradoxical psychological effects of lysergic acid diethylamide (LSD).
Carhart-Harris RL; Kaelen M; Bolstridge M; Williams TM; Williams LT; Underwood R; Feilding A; Nutt DJ
Psychol Med; 2016 May; 46(7):1379-90. PubMed ID: 26847689
[TBL] [Abstract][Full Text] [Related]
14. Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1-cyclopropanoyl-d-lysergic acid diethylamide (1CP-LSD).
Brandt SD; Kavanagh PV; Westphal F; Stratford A; Odland AU; Klein AK; Dowling G; Dempster NM; Wallach J; Passie T; Halberstadt AL
Drug Test Anal; 2020 Jun; 12(6):812-826. PubMed ID: 32180350
[TBL] [Abstract][Full Text] [Related]
15. LSD modulates effective connectivity and neural adaptation mechanisms in an auditory oddball paradigm.
Timmermann C; Spriggs MJ; Kaelen M; Leech R; Nutt DJ; Moran RJ; Carhart-Harris RL; Muthukumaraswamy SD
Neuropharmacology; 2018 Nov; 142():251-262. PubMed ID: 29101022
[TBL] [Abstract][Full Text] [Related]
16. LSD, afterglow and hangover: Increased episodic memory and verbal fluency, decreased cognitive flexibility.
Wießner I; Olivieri R; Falchi M; Palhano-Fontes F; Oliveira Maia L; Feilding A; B Araujo D; Ribeiro S; Tófoli LF
Eur Neuropsychopharmacol; 2022 May; 58():7-19. PubMed ID: 35158230
[TBL] [Abstract][Full Text] [Related]
17. LSD modulates music-induced imagery via changes in parahippocampal connectivity.
Kaelen M; Roseman L; Kahan J; Santos-Ribeiro A; Orban C; Lorenz R; Barrett FS; Bolstridge M; Williams T; Williams L; Wall MB; Feilding A; Muthukumaraswamy S; Nutt DJ; Carhart-Harris R
Eur Neuropsychopharmacol; 2016 Jul; 26(7):1099-109. PubMed ID: 27084302
[TBL] [Abstract][Full Text] [Related]
18. Acute Effects of Lysergic Acid Diethylamide on Circulating Steroid Levels in Healthy Subjects.
Strajhar P; Schmid Y; Liakoni E; Dolder PC; Rentsch KM; Kratschmar DV; Odermatt A; Liechti ME
J Neuroendocrinol; 2016 Mar; 28(3):12374. PubMed ID: 26849997
[TBL] [Abstract][Full Text] [Related]
19. Beyond LSD: A Broader Psychedelic Zeitgeist during the Early to Mid-20
Aday JS; Bloesch EK; Davoli CC
J Psychoactive Drugs; 2019; 51(3):210-217. PubMed ID: 30836890
[TBL] [Abstract][Full Text] [Related]
20. Hyperthermic effects of D-lysergic acid diethylamide (LSD) and its derivatives in rabbits and rats.
Hashimoto H; Hayashi M; Nakahara Y; Niwaguchi T; Ishii H
Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):314-21. PubMed ID: 303504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
